Evidence map›Paper›PMID 34991490›Full record

ArticleBMC cardiovascular disorders2022

High prevalence and low awareness of hyperuricemia in hypertensive patients among adults aged 50-79 years in Southwest China.

Yang Zhang, Feng-Qin Nie, Xiao-Bo Huang, Weiwei Tang, Rong Hu, Wen-Qiang Zhang, Jian-Xiong Liu, Rong-Hua Xu, Ya Liu, Dong Wei and 2 more

Open access · goldAbstract read
In one paragraph

Article in BMC cardiovascular disorders, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 10 citations in OpenAlex.

  1. Effects of Sacubitril/Allisartan versus Olmesartan on serum uric acid in Chinese patients with hypertension and hyperuricaemia.Hypertension research : official journal of the Japanese Society of Hypertension · 2026
    Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 2 countries.

Yang ZhangDepartment of Cardiology, Second People's Hospital of Chengdu, Chengdu, China.
Feng-Qin Nie *Department of Endocrinology, The People's Hospital of Wenjiang, Chengdu, China.
Xiao-Bo Huang *Department of Cardiology, Second People's Hospital of Chengdu, Chengdu, China.
Weiwei TangSchool of Health Policy and Management, Nanjing Medical University, Nanjing, Jiangsu, China.
Rong HuDivision of Cardiology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Wen-Qiang ZhangDepartment of Epidemiology and Health Statistics, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, Sichuan, China.
Jian-Xiong LiuDepartment of Cardiology, Second People's Hospital of Chengdu, Chengdu, China.
Rong-Hua XuStroke Center, Second People's Hospital of Chengdu, Chengdu, China.
Ya LiuDepartment of Geriatrics, Second People's Hospital of Chengdu, Chengdu, China.
Dong WeiDepartment of Endocrinology and Metabolism, Second People's Hospital of Chengdu, No. 10, Qingyun South Street, Chengdu, 610017, Sichuan Province, China. weidong3.14@163.com.
Tzung-Dau WangCardiovascular Center and Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital, No. 7, Zhong-Shan South Road, Taipei City, 10002, Taiwan, China. tdwang@ntu.edu.tw.
Xu FanDepartment of Public Health, CHENGDU Medical College, Sichuan, 610500, China. xufan@cmc.edu.cn.
Chengdu Second People's Hospital · CNChengdu Medical College · CNDalian Medical University · CNNanjing Medical University · CNNational Taiwan University Hospital · TWWest China Medical Center of Sichuan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThis study was aimed to assess the prevalence of hyperuricemia and its associated risk factors among hypertensive patients in Southwest China.

methodsFrom September 2013 to March 2014, a multistage, stratified sampling was conducted on 3505 hypertensive people aged 50-79 years who lived in urban communities within Chengdu and Chongqing, using a questionnaire and performing physical and biochemical measurements.

resultsIn the study population, approximately 18.2% of all hypertensive participants had hyperuricemia (638/3505), with a prevalence rate of 21.5% in men and 16.2% in women (p < 0.05). Multivariate logistic regression analysis showed that aging, without spouse, current drinking, preferring hotpot, hypertriglyceridemia, BMI ≥ 25 kg/ m DISCUSSION: Improved hyperuricemia health knowledge should be delivered to improve public awareness of the disease and it may need aggressive strategies aiming at the prevention and treatment of hyperuricemia. It is may necessary to encourage people to check blood uric acid levels when they first time to be diagnosed with hypertension, especially in the elderly.

Indexed as

AgedChinaFemaleHumansHypertensionHyperuricemiaMaleMiddle AgedPrevalenceRisk FactorsRural PopulationSex FactorsUrban PopulationUric AcidUric Acid

Identifiers

PMID34991490
PMCPMC8740372
OpenAlexW4206169524

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.